(Q60637150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

meta-analysis

0 references

title

Meta-analysis of double-blind placebo-controlled trials of antidepressants and benzodiazepines for patients with panic disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference

1 reference

Matteo Balestrieri

2

0 references

author name string

G Wilkinson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

M Balestrieri

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

M Ruggeri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

C Bellantuono

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

language of work or name

English

0 references

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

991-998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

23 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Why do we need systematic overviews of randomized trials?

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Distribution Theory for Glass's Estimator of Effect size and Related Estimators

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Combined pharmacological and behavioral treatment for agoraphobia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

A measure to aid in the interpretation of published clinical trials.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Specialist mental health treatment in general practice: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Behavior Therapy, Supportive Psychotherapy, Imipramine, and Phobias

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

The file drawer problem and tolerance for null results

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

Meta-analysis of psychotherapy outcome studies

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700029986

7 January 2021

10.1017/S0033291700029986

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1685792%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference